These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

749 related items for PubMed ID: 17552924

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Recent advances in clinical oncoproteomics.
    Jain KK.
    J BUON; 2007 Sep; 12 Suppl 1():S31-8. PubMed ID: 17935275
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Strategies for plasma proteomic profiling of cancers.
    Omenn GS.
    Proteomics; 2006 Oct; 6(20):5662-73. PubMed ID: 16991194
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
    Calvo KR, Liotta LA, Petricoin EF.
    Biosci Rep; 2005 Oct; 25(1-2):107-25. PubMed ID: 16222423
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A, Ma PC, Salgia R.
    Mass Spectrom Rev; 2007 Oct; 26(3):451-66. PubMed ID: 17407130
    [Abstract] [Full Text] [Related]

  • 12. Proteomics analysis in lung cancer: challenges and opportunities.
    Kikuchi T, Carbone DP.
    Respirology; 2007 Jan; 12(1):22-8. PubMed ID: 17207021
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Protein microarrays for cancer diagnostics and therapy.
    Lin JC.
    Med Princ Pract; 2010 Jan; 19(4):247-54. PubMed ID: 20516699
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical proteomics and mass spectrometry profiling for cancer detection.
    Solassol J, Jacot W, Lhermitte L, Boulle N, Maudelonde T, Mangé A.
    Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703
    [Abstract] [Full Text] [Related]

  • 17. Clinical proteomics in breast cancer: a review.
    Gast MC, Schellens JH, Beijnen JH.
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [Abstract] [Full Text] [Related]

  • 18. Integrative oncoproteomics strategies for anticancer drug discovery.
    Liu R, Wang K, Yuan K, Wei Y, Huang C.
    Expert Rev Proteomics; 2010 Jun; 7(3):411-29. PubMed ID: 20536311
    [Abstract] [Full Text] [Related]

  • 19. Current trends in computational inference from mass spectrometry-based proteomics.
    Webb-Robertson BJ, Cannon WR.
    Brief Bioinform; 2007 Sep; 8(5):304-17. PubMed ID: 17584764
    [Abstract] [Full Text] [Related]

  • 20. Proteomics-driven cancer biomarker discovery: looking to the future.
    Simpson RJ, Bernhard OK, Greening DW, Moritz RL.
    Curr Opin Chem Biol; 2008 Feb; 12(1):72-7. PubMed ID: 18295612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.